Editorial Policies

Aims and Scope

The purpose of the Russian Military Medical Academy Reports includes making a significant contribution of regional medical publications to the Russian and international scientific and information space with the formation of scientific communications, the creation of a wide authorial asset and a mass readership. The journal is focused on providing scientific and practical, information-analytical and methodological assistance in the professional activities of specialists aimed at developing advanced medical technologies and uncovering the latest scientific achievements. The journal publishes original scientific articles, presenting the results of experimental and clinical research, scientific reviews, reflecting the results of research in various fields of medicine, materials describing clinical cases, information of biographical and historical-medical nature.

The journal publish articles in several sections:

  • Chronicle
  • Fundamental problems of modern medicine
  • Reviews
  • Clinical medicine
  • Health Care organization
  • Military and extreme medicine
  • Preventive medicine
  • Pharmacy
  • Biomedical research
  • Psychophysiology and medical psychology
  • Educational technology
  • History of medicine




Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Original articles

The volume of the article is up to 3000 words (including sources of literature, captions to figures and tables), up to 15 sources of literature. The summary should be structured, contain 5 paragraphs (“Purpose”, “Material and Methods”, “Results”, “Conclusion”, “Keywords”) and not exceed 300 words.

The section includes:

  • clinical and experimental studies.
  • new theories or ways to solve a problem.

Original research should be designed in accordance with the IMRAD format.

The editorial board strongly recommends observing the following standards for the presentation of their scientific research, depending on its type:

  • parallel group randomized trialsCONSORT standard;
  • observational studies – STROBE standard;
  • clinical trials – SPIRIT standard;
  • diagnostic accuracy studies – STARD standard;
  • clinical case reporting – CARE standard;
  • clinical practice guidelines – AGREE standard;
  • qualitative research – SRQR standard;
  • preclinical animal studies – ARRIVE standard;
  • quality improvement reporting SQUIRE standard;
  • health economic evaluation reporting – CHEERS

All clinical and preclinical studies must be approved by the ethics committee.

All studies involving vulnerable populations should be conducted in accordance with international ethical principles.

The conclusion of the ethics committee is obligatory if any biomaterials were collected.

The editorial board has the right to request from the authors a copy of the conclusion of the ethics committee. Researchers must obtain voluntary informed consent from patients or their legal representatives to participate in the study.

Consent form-must be approved by the ethics committee.

Full information is presented in the Ethical Code of the "Eco-Vector" publishing house.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Clinical Practice Guidelines

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case report

Checked Open Submissions Checked Indexed Checked Peer Reviewed


Checked Open Submissions Checked Indexed Checked Peer Reviewed

History of medicine

Checked Open Submissions Checked Indexed Checked Peer Reviewed


Checked Open Submissions Checked Indexed Unchecked Peer Reviewed


Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letter to Editor

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Book reviwew

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Conference proceedings

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

Every scientific manuscript submitted to Russian Military Medical Academy Reports is subject to double blind peer-review (reviewers are not informed of manuscript authors’ names, authors are not informed of reviewers’ names).

1. Articles are reviewed by editorial board members and invited reviewers – leading specialists in relevant fields of medicine, highly proficient and experienced in the field of interest which is close to the thematic focus of the manuscript. All the reviewers are acknowledged experts in the subject matter of reviewed materials and have a number of publications on the subject matter of the reviewed article over the last three years.

2. The decision on choosing a particular reviewer for reviewing the article is made by the editor-in-chief or the deputy editor-in-chief. The reviewing takes 2 to 4 weeks but can be extended if required by the reviewer.

3. The review procedure is confidential. Reviewers are notified that manuscripts submitted for their review are their authors’ intellectual property and should be treated as information that is not subject to disclosure. Reviewers are not allowed to make copies of manuscripts for their personal needs. Breach of confidentiality is allowed only in case the material is declared to be invalid or falsified. The author of the reviewed work is given the opportunity to read the text of the review.

4. Each reviewer is entitled to refuse to perform the reviewing in case any explicit conflict of interests exists impacting his/her perception or interpretation of manuscript materials. Besides, he/she can ask the editor-in-chief to suspend him/her from the reviewing in case of insufficient expertise for reviewing this manuscript or shortage of time for performing this work in time.

5. The review must contain expert evaluation of the manuscript against the following parameters: correspondence between content of the article and its title; urgency of the study; scientific novelty of the results, reasonability of publishing the article considering the thematic scope of the journal and literature on this subject matter published earlier; material presentation (language, style, used categories and expressions), accuracy in factual data descriptions.

6. As a result, each reviewer gives his/her recommendations on further dealing with the article (each reviewer’s decision is to be justified):
• the article is recommended for publication as it is;
• the article is recommended for publication after the faults discovered by the reviewer are eliminated;
• the article requires further reviewing by another expert;
• the article is not recommended for publication in the journal.

7. If the review contains recommendations to correct or improve the article the editorial board of the journal provides the author with the text of the review suggesting to take them into account when a new version of the article is prepared or to refute them (partially or in full) in a well-argued manner. Article improvement cannot take longer than 2 weeks starting from the moment of an e-mail to its authors notifying them of amendments required. The article improved by the author is subject to reviewing again.

8. If the authors refuse to amend the materials they must notify the editorial board in written or verbally of their refusal to have the article published. If the authors do not return an amended version within 3 months after the review is sent to them even if the authors do not explicitly refuse to amend the article the editing board strikes it off the list. In such cases authors are notified accordingly of their manuscripts being stroke off the list due to expiry of time meant for amendments.

9. If the author and the reviewer have faced any irreconcilable differences regarding the manuscript the editorial board is entitled to submit the manuscript for further reviewing. In conflict situations the decision is made by the editor-in-chief at the editorial board meeting.

10. The decision on refusal to publish a manuscript is made at the editorial board meeting with reviewers’ recommendations taken into account. The article not recommended for publication according to the editorial board’s decision is not reaccepted. The author is provided with a notice of publication refusal and a copy of the review by e-mail.

11. After the editorial board of the journal decides to accept an article for publication the editors office notifies the author accordingly and informs him/her of the issue date.

12. A positive review does not guarantee publication of the article. The final decision is made by the editorial board. In conflict situations the decision is made by the editor-in-chief.

13. The following materials are not accepted for publication:

  • articles which are not executed in accordance with the article submission guidelines and the authors of which refuse to adjust them accordingly.
  • articles the authors of which do not take reviewers’ meaningful comments into account or do not refute them in a well-argued manner.

14. The editors office sends copies of reviews to the Ministry of Education and Science of the Russian Federation upon request.

15. Original reviews are kept in the editors office for 5 years.


Publication Frequency

Quarterly publication (4 issues annualy). Articles are published in accordance with the submission and acceptance dates. Possible publication in the journal within conference proceedings, special issues and applications. 


Open Access Policy

The journal offers full open access with permitted reuse to meet the needs of authors and maximize article visibility.

The publications in the Journal are available to all interested from the moment of publication. So, this journal provides immediate Open Access (in accordance with Budapest Open Access Initiative) to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Also the editorial board believes that it provides free public access to the results of research and contributes to the advancement of science and medicine.

All accepted articles publish with the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) for more freely distribution and usage worldwide.



The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.


Editor rejection

Reasons for rejection of manuscripts by the editor without transfer to reviewers:

  • The design of the manuscript does not meet the requirements of the journal;
  • the manuscript does not meet the criteria of any of the journal section;
  • the volume of the manuscript significantly exceeds the maximum allowable one;
  • the materials of the manuscript do not contain illustrative material, statistical analysis of the results obtained, or are presented in an exceptionally concise form, which does not allow assessing the quality of the presented material.


Publishing Ethics

Extract from the Code of Ethics of Eco-Vector LLC (download full text)

Publisher and Editorial

 Independently and impartially make decisions about publication:

  • Reject;
  • Resubmit;
  • Accept;
  • Retract.

Responsibility and rights of authors

 When submitting a manuscript to a journal, authors should ensure that:

  • all participants who have made a significant contribution to the study are presented as Co-Authors;
  • those who did not participate in the study are not listed as Co-Authors;
  • all Co-authors saw and approved the final version of the work and agreed to submit it for publication (this is confirmed by the signatures of all authors in the cover letter).

The author should not

  1. hide any conflicts of interest that may affect the result and interpretation of the work (*);
  2. publish the submitted manuscript in other publications and hide from the Editorial Office the transfer of the manuscript to another publication (**);
  3. deviate or ignore the Journal's instructions for preparing and sending manuscripts, instructions for working with proofreading instructions regarding deadlines and other instructions of the Editorial Board;
  4. evaluate the work of reviewers.

Violation of the prohibitions will be regarded by the editors as unethical behavior. The manuscript may be rejected by the Editors

In case of violation of paragraph 3, the Publishing House informs the Editor-in-Chief about the unethical behavior of the authors.

The authors adhere to:

  • publication ethics;
  • instructions for submitting a manuscript to the journal;
  • the instructions contained in the letters received and the deadlines indicated in them;
  • instructions for working with proofreading.

The authors have the right to:

  • withdraw the article at any stage of its consideration
  • report the discovery of significant errors in a published article

 Responsibility and rights of Reviewers

The reviewer should not

  • participate in the review of manuscripts in case of conflicts of interest due to competitive, joint and other interactions and relationships with any of the Authors, companies or other organizations associated with the submitted work;
  • use unpublished data obtained from submitted manuscripts in personal research without the written consent of the Author;
  • discuss the manuscript with anyone not authorized to do so by the Editor.

Reviewers should

  • inform the Editor about the discovery of a significant similarity or coincidence between the manuscript in question and any other published work that is within the scientific competence of the Reviewer;
  • keep confidential and not use information or ideas obtained during the review for personal gain.
  • avoid personal criticism of the Author and try to give an objective assessment of the manuscript.


If animals or people were involved in the work as objects of research, the manuscript should indicate that all stages of the study comply with the legislation and regulatory documents of research organizations and are also approved by the relevant ethical committees.

The authors are obliged to follow ethical principles of conducting medical research involving people, animals, and vulnerable populations.

Patients and respondents participating in a study should be fully informed about the purpose of the study, its results, and the consequences of participating in the study.

 Vulnerable populations include

  • women of reproductive age, minors, elderly and senile patients, people with mental, cognitive and sensory disorders,
  • patients in an emergency, terminally ill or unable to give informed consent,
  • small ethnic groups

 The editors have the right to request

a copy of the opinion of the ethical committee, informed consents, copies of questionnaires, etc.

The editors refer the following to violations of publication ethics:

  • illegal borrowing of text, figures, tables;
  • simultaneous submission of a manuscript to several journals;
  • concealment of a conflict of interest;
  • assessment of the professional qualities of reviewers;
  • illegal co-authorship;
  • multiple publications.

(*) Examples of potential conflicts of interest to be disclosed:

  • receiving financial rewards for participating in a study or writing a manuscript;
  • any connection (contract work, consulting, shareholding, receiving fees, providing expert opinions) with organizations that have a direct interest in the subject of the study or review;
  • patent application or patent registration for research results (copyright, etc.);
  • obtaining financial support for any stage of the research or writing of the manuscript (including grants and other financial support).
  • Information about conflicts of interest received from the authors of the manuscripts should be available only to the editorial board when deciding whether to publish the manuscript. Then information about conflicts of interest should be published as part of the full text of the article.
  • The publisher recommends using the interactive form at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf when writing this part of the manuscript.

(**) The publication of a certain type of article (for example, translated articles) is permitted in some cases, subject to a number of conditions. When submitting a manuscript for secondary publication, the authors must notify the editorial board about this and justify in detail the feasibility of such publication. In the case of a secondary publication, the settlement of issues related to copyright for publication is decided individually in each specific case. The general rules for preparing a manuscript for a "secondary" publication are: indicating a full bibliographic reference to the primary publication, preserving the original bibliography of the primary work.


Attribution of authorship

Editorial board emphasize that:

Only those persons who have made a significant contribution to the conception of the work, the development, execution, and/or interpretation of the results of the presented study, as well as to the process of writing the manuscript (including scientific and stylistic editing and design in accordance with the requirements of the journal) may be recognized as the Authors of the publication.

When submitting a manuscript to the journal, Authors shall ensure that:

  • All participants who made a significant contribution to the reported study are presented as Co-Authors;
  • Those who did not participate in the study are not listed as Co-Authors;
  • All Co-Authors have read and approved the final version of the paper and agreed to its submission for publication—this shall be confirmed by the signatures of all Authors in the cover letter.

Identification of illegal borrowings is carried out:

  • as part of scientific peer review;
  • through the ANTI-PLAGIARISM system.

At this stage of expertise:

  • The editors do not take into account the percentage of originality calculated by the anti-plagiarism program;
  • The editors relies only on an expert analysis of the full report of the program;
  • The editors allow for complete coincidence in the description of the applied research methods with such in previously published articles, textbooks, manuals.;
  • The editors believe that the introduction, results, discussion and conclusion (conclusions) should be completely original.

If conclusions coincide with those formulated earlier by other researchers, this should be explicitly indicated in the manuscript in the discussion section.


Authors Conflicts of Interest Disclosure form

All Authors must disclose in their manuscript ― declare in the appropriate section of the manuscript ― any financial or other relevant interests that might be construed to influence the findings or interpretation of their research.

Examples of potential conflicts of interest to be disclosed are given below:

  • Receiving financial rewards for participating in the research or writing of a manuscript;
  • Any affiliation (contract work, consulting, equity assets, fees, and expert opinions) with organizations that have a direct interest in the subject matter of the research or review;
  • A patent application or registration for research findings (copyright, etc.);
  • Receiving financial support for any of the stages of conducting the research or writing a manuscript (including grants and other forms of financial support).

Information on conflicts of interest received from the Authors of manuscripts should be available only to the Editorial Board when deciding whether to publish the manuscript. Such information on conflicts of interest shall then be published as part of the full text of the paper.

When writing this part of the manuscript, the Publisher recommends using the interactive form available at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf

A Reviewer shall not participate in the review of manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with any of the Authors, companies, or other organizations related to the submitted paper.

Editors recuse themselves from reviewing manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with Authors, companies, and possibly other organizations related to the manuscript.


Confidentiality and personal data

The Editor and the Editorial Board shall not unnecessarily disclose information on the manuscript under consideration to anyone other than the Authors, Reviewers, possible Reviewers, other Academic Advisors, and the Publisher.

The Editor shall not use unpublished materials disclosed in the submitted manuscript in the Editor’s own research without the written consent of the Author.

Reviewers shall not use unpublished materials from the submitted manuscripts in the Reviewer’s own research without the written consent of the Author.

Reviewers must keep information or ideas obtained during the review process confidential and not use them for personal gain.

Reviewers shall not discuss the manuscript with any person not authorized by the Editor.

Identifiable (personal) information, including patient names and initials or hospital numbers, shall not be published in written descriptions, photographs, and genetic pedigrees unless the information is of great scientific or historical value and the patient (or parent or guardian) gives written consent for its publication.

Ethical guidelines for handling personal data in biomedical research involving human subjects must comply with legal acts, such as the:

  • Council for International Organizations of Medical Sciences (CIOMS);
  • International Ethical Guidelines for Health-Related Research Involving Humans (2016)―in particular, Guideline No. 12 “Collection,
  • Storage and Use of Data in Health-Related Research” ― as well as the Russian Federal Law on Personal Data (No. 152-FZ), implemented on July 27, 2006 .



Retraction’s reasons

The retraction of an already published article is an extreme measure and is applied in the event of the disclosure of facts that were not known during the review.

Reasons for retraction are as follows:

  • detection of incorrect borrowings (plagiarism) in the publication;
  • duplication of the article in several publications;
  • detection of falsifications or fabrications in the work (for example, manipulation of experimental data);
  • detection of serious errors in the work (for example, misinterpretation of the results), which calls into question its scientific value;
  • detection of persons who do not meet the criteria for authorship;
  • a conflict of interest was not announced;
  • article was republished without the consent of the author;
  • the article has not been peer reviewed.

Retraction procedure:

  • Authors, readers, reviewers, editors, and the Publisher can initiate a retraction of a paper by application to the editorial office of the Journal.
  • The Retraction Commission reviews the received application and notifies the interested parties about the beginning of the retraction procedure.
  • The Retraction Commission decides to retract the published paper if there are sufficient facts in favor of retraction.
  • The Retraction Commission notifies the initiator of the retraction of the paper about the results of consideration in written form.
  • If the commission decides to retract the paper, the Journal publishes information that the paper has been retracted, including the metadata of the retracted paper.
  • If papers from the Journal are indexed by any databases, a letter is sent to these databases stating that this paper has been retracted, indicating the reasons for retraction.
  • The editorial board has the right to independently decide on additional sanctions – for example, on the inclusion of authors in the blacklist of the Journal for a certain period, or indefinitely.



The Editorial Board may grant Authors the right to appeal editorial decisions on the acceptance or rejection of papers.

The protocol of actions of the Editorial Board in case of receiving an appeal shall be described on the journal’s website.

Appeal Mechanism

  1. If the Author does not agree with the decision of the Editorial Board on the acceptance or rejection of the paper, the Author may appeal to the Editorial Board in writing, clearly indicating the reasons for the appeal.
  2. The Author’s appeal shall be considered by the Conflict Resolution Commission.
  3. The Editorial Board may change its decision in the following cases:
  • The Author provided additional findings that were not considered in the initial review of the paper.
  • The Author provided additional materials to the manuscript, which were not considered during the initial review of the paper.
  • The Author provided information on the conflict of interest, which was not provided during the initial review of the paper.
  • The Author expressed concern about a biased review.
  1. If there are sufficient grounds, the Conflict Resolution Commission shall make a proposal to the Editorial Board to change or uphold the initial decision on the publication of the paper.
  2. If necessary, the Editorial Board may engage an additional Reviewer to make the final decision.
  3. The decision on the acceptance or rejection of the paper based on the results of the revision of the primary decision shall be made by the Editorial Board.
  4. The decision of the Editorial Board based on the results of the revision of the primary decision shall be final and not subject to re-appeal.


Issues upload

Published articles are sent to the Scientific electronic libraries (eLibrary.ru) within three weeks after publication of all language versions at the official journal site.


Author fees

The publishing house does not charge authors for publishing articles in open access, reviewing, preparing the journal for publication, as well as the content of the website and electronic deposit of manuscripts.


Advertising policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).


  1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
  4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
  • Alcohol
  • Tobacco
  • Weapons, firearms, ammunition
  • Fireworks
  • Gambling and lottery
  • Pornography or related themes
  • Political and religious advertisements
  • Advertisements that claim to have a “miracle” cure or method
  • Advertisements that make unsubstantiated health claims for the products advertised
  • Advertisements directed at children
  1. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  2. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  3. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  4. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  5. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  6. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  7. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  8. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  9. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  10. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  11. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  12. The following online advertising formats are prohibited:
  • Pop-ups and floating advertisements.
  • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
  • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
  • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/



Readers and authors of the journal can connect to the RSS feed to receive up-to-date information about the journal.

As part of scientific and practical events (conferences, symposiums), participants are provided with a free copy of the journal.

The publisher does not send requests to potential authors to submit manuscripts.

The publisher provides an opportunity for reviewers to submit a review to Publons.


Post-publishing changes

As part of the policy of post-publishing changes, the following types of articles are published in the journal.


A variety of Erratum. The article does not report errors but clarifies the data of a previously published article.


Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.


Letter to the editor or a reply to the letter.


An article describing the corrections made in an article previously published in the same journal. This type of publication is not a variant of Erratum.


Article in which errors are reported that were made by authors in an earlier publication in the same journal.


Accidental duplication of an article in another Eco-Vector's journal. The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is a duplicate.


Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance t


Article in which errors are reported that were made in an earlier publication in the same journal. Can be Erratum (publishing error) but also Corrigendum (author error).

Expression of Concern

A notification about the integrity of a published article that is typically written by an editor and should be labelled prominently in the item title. It is the responsibility of the editor to initiate appropriate investigative procedures, discover the outcome of the investigation, and notify readers of that outcome in a subsequent published item. The outcome may require the publication of a retraction notice.


Editorial notice of the removal of a previously published article.

The text of the article is removed. The HTML pages and PDF pages of the article are completely removed and replaced by a single page with citation details and an explanation.

Retracted publication

The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is retracted.

Retraction of Publication

Editorial notice of the retraction of a previously published article.


Refutation of an article previously published in the same journal (in a situation where retraction cannot be performed).

For details see Crossmark Policy.


Manuscript submission

If you have read the editorial policy and found that the results of your research correspond to the subject of the journal, you may get to the manuscript submission page.


Accepted manuscripts

The accepted manuscript is submitted to the scientific editor. From this moment on, the authors are strictly prohibited from making any changes to the text of the manuscript without the consent of the scientific editor.

After agreeing on all changes with the scientific editor, the authors will have to upload the final version of the manuscript to their personal account on the website (Word file).

At the next stage, the manuscript will be handed over to the layout editor to create an electronic layout of the article.

This file (proofreading) will be sent to the authors in pdf format for final approval.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies